Topiramate for anger control: A systematic review

Indian Journal of Pharmacology

Volumn 42, Issue 3, 2010, Pages 135-141

  Varghese, Bindu Susan ^a   Rajeev, A ^a   Norrish, Mark ^a   Al Khusaiby, Saleh Bin Mohammed ^a  

^a OMAN MEDICAL COLLEGE   (Oman)

Author keywords

Aggression; anger control; topiramate

Indexed keywords

RECREATIONAL DRUG; TOPIRAMATE;

AGGRESSION; ANGER; BACKACHE; BEHAVIOR DISORDER; BORDERLINE STATE; CHRONIC PAIN; CLINICAL TRIAL; COCHRANE LIBRARY; COMORBIDITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; EPILEPSY; FOLLOW UP; HAMILTON SCALE; HOSTILITY; HUMAN; IMPULSIVENESS; LONG TERM CARE; LOW BACK PAIN; MAJOR DEPRESSION; MEDLINE; MENTAL DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RATING SCALE; REVIEW; RISK REDUCTION; SCORING SYSTEM; SEX DIFFERENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 77955456607     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.66834     Document Type: Review

References (26)

1. Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. West Sussex, England.The Cochrane Collaboration; 2008.
2. Vinson DC, Arelli V. State anger and the risk of injury: A case control and crossover study. Ann Fam Med 2006;4:63-68
3. Spielberger CD. State-Trait Anger Expression Inventory: Professional Manual. Odessa, FL: Psychological Assessment Resources; 1996.
4. Reich J, De Girolamo G. Epidemiology of DSM III personality disorders in the community and clinical populations. In: Loranger AW, Janca A, Sartorius N, editors. Assessment and Treatment of Personality Disorders: The ICD 10 International Personality Disorder Examination (IPDE). Cambridge: Cambridge University Press; 1997.
5. Weissman MM. The epidemiology of personality disorders: A 1990 update. J Person Disord (Spring Suppl) 1993;7:44-62.
6. Moran P. Antisocial personality disorder: An epidemiological perspective. London: Gaskell; 1999.
7. Maden A., Curle C., Meux C., Burrow S. and Gunn J. The treatment and security needs of patients in special hospitals. Crim Behav Ment Health 1993;3:290-306.
8. Stewart ME. Adolescents in a therapeutic community: Treatment implications for teen survivors of traumatic experiences. J Psychoactive Drugs 1994;26:409-419
9. Mark VH, Ervin FR. Violence and the Brain. New York: Harper and Brown; 1970.
10. Guay DR. Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability. Consult Pharm 2007;22:1004-1034
11. Gobbi G, Gaudreau PO, Leblanc N. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis. J Clin Psychopharmacol 2006;26:467-473
12. Canitano R. Clinical experience with topiramate to counteract neurolepticinduced weight gain in 10 individuals with autistic spectrum disorders. Brain Dev 2005;27:228-232
13. Reith D, Burke C, Appleton DB, Wallace G, Pelekanos J. Tolerability of topiramate in children and adolescents. J Paediatr Child Health 2003;39:416-419
14. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 1997;28:167-179
15. Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, et al. Topiramate treatment for aggression in female borderline personality disorder patients: A double blind, placebo controlled study. J Clin Psychiatry 2004;65:1515-1519
16. Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, et al. Treatment of aggression with topiramate in male borderline patients: A double blind placebo controlled study. Biol Psychiatry 2005;57:495-499
17. Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P. Topiramate in treatment of depressive and anger symptoms in female depressive patients: A randomised double blind placebo controlled study. J Affect Disord 2005;87:243-252
18. Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, et al. Topiramate in treatment of patients with chronic low back pain: A randomized double blind, placebo study. Clin J Pain 2006;22:526-531
19. Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, et al. Topiramate treatment for women with borderline personality disorder: A double blind placebo controlled study. J Clin Psychopharmacol 2006;26:61-66
20. Nickel MK, Loew TH. Treatment of aggression with topiramate in male borderline patients, Part II: 18-month follow-up. Eur Psychiatry 2008;23:115-117
21. Nickel MK. Topiramate reduced aggression in female patients with borderline personality disorder. Eur Arch Psychiatry Clin Neurosci 2007;257:432-433
22. Nickel MK. Topiramate treatment of aggression in male borderline patients. Aust N Z J Psychiatry 2007;41:461-462
23. Kossoff EH, Pyzik PL. Improvement in alertness and behavior in children treated with combination topiramate and vagus nerve stimulation. Epilepsy Behav 2004;5:256-259
24. Fhager B, Meiri IM, Sjogren M, Edman A. Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: A retrospective pilot study. Int Psychogeriatr 2003;15:307-309
25. Janowsky DS, Kraus JE, Barnhill J, Elamir B, Davis JM. Effects of topiramate on aggressive, self-injurious and disruptive behaviors in the intellectually disabled: An open label retrospective study. J Clin Psychopharmacol 2003;23:500-504
26. Mula M, Trimble MR. The importance of being seizure free: Topiramate and psychopathology in epilepsy. Epilepsy Behav 2003;4:430-434